1. This section shall not apply to the study and/or research of the effects of the release of ozone-depleting compounds into the environment and/or the development of alternative technologies, where such compounds are necessary for conducting such study and research.

2. This section shall not apply to any ozone-depleting compound used as a coolant in any refrigeration or air conditioning unit or system.

3. Subsection A of this section shall not apply to any licensed health care facility operated either for profit or not for profit, including any medical research conducted at such facility, nor to manufacturers of any "drug" and/or any medical "device" as the terms "drug" and "device" are defined in Title 21 U.S.C. Sections 321(g)(1) and 321(h) of the Federal Food, Drug and Cosmetic Act, but only if the manufacturer is required to comply with the Good Manufacturing Practice requirements adopted pursuant to Title 21 U.S.C. Section 360j(f). This exemption is valid until such time as safe and effective alternatives to the current use of ozone-depleting compounds by the licensed health care facility or manufacturer of drugs and/or medical devices are available, as determined by the City and approved by council. All manufacturers of drugs and/or medical devices that utilize ozone-depleting compounds as sterilants shall adopt and implement a recycling system whereby any such ozone-depleting compound used by such manufacturers shall be recaptured and recycled.

4. This section shall not apply to any establishment manufacturing a product or component product under contract with any branch of the United States Armed Forces for which applicable military specifications require the use of an ozone-depleting compound. Such establishment shall adopt and implement a recycling system whereby any ozone-depleting compound used as a solvent shall be recaptured and recycled. (Ord. 6031-NS § 3, 1991)